Osteoarthritis Initiative (OAI): A Knee Health Study

Back to Search
Print
Bookmark Trial

NCT00080171

Last updated date
Back to Search
Print
Bookmark Trial
FOR MORE INFORMATION
Study Location
University of Maryland
Baltimore, Maryland, 21201, United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoarthritis, Knee Osteoarthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
45-79 years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Must meet one of the following criteria:

- Overweight

- Previous knee injury or surgery

- Knee pain during the past year. Participants do not need to have current knee pain to take part in the study.

- Parent or sibling who had knee replacement

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


- Rheumatoid arthritis


- Joint replacements in both knees


- Unable to walk without assistance


- Unable to undergo MRI of the knee

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

Call Now
pfizer-logoClinical Trials
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
Learn more ›

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

Based on your search, you may also be interested in

Osteoarthritis, Knee OsteoarthritisOsteoarthritis Initiative (OAI): A Knee Health Study
NCT00080171
  1. Baltimore, Maryland
  2. Baltimore, Maryland
  3. Columbus, Ohio
  4. Pittsburgh, Pennsylvania
  5. Pawtucket, Rhode Island
ALL GENDERS
45 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title Osteoarthritis Initiative (OAI): A Knee Health Study
Official Title Osteoarthritis Initiative (OAI): A Knee Health Study
Brief Summary Knee osteoarthritis (OA) is the most common cause of disability in adults. The "Osteoarthritis Initiative (OAI): A Knee Health Study" is a nationwide research study that will help researchers gather more information about the physical changes that occur prior to the onset of arthritis symptoms or before OA gets worse. The purpose of this study is to examine people who have knee OA or are at high risk for knee OA; information will be used to better understand how to prevent and treat knee OA.
Detailed Description

Knee OA causes more health problems and medical expenses that any other form of arthritis. Symptoms of OA can range from stiffness and mild pain to severe joint pain and even disability. Previous research has shown that certain factors, such as knee pain, prior knee injury or knee surgery, OA of the hand, or obesity, may lead to knee OA. The OAI is a multicenter, observational study of knee OA that will collect information on potential biomarkers for OA and trends in OA onset and progression.

The OAI will recruit and follow participants who have knee OA or are at high risk for developing knee OA for an eight-year period at one of four clinical centers. Blood and urine collection, magnetic resonance imaging (MRI), and X-rays will be completed at each of four annual follow-up visits. A questionnaire and physical examination at screening will assess for risk factors for the development and progression of knee OA. Levels of knee pain and physical disability will be assessed at study start and at each of the follow-up visits by questionnaire and examination.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples With DNA
Description:
Blood, urine
Sampling Method Non-Probability Sample
Study Population Participants who have knee OA or are at high risk for developing knee OA
Condition
  • Osteoarthritis
  • Knee Osteoarthritis
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: September 25, 2020)		4796
Original Enrollment
 (submitted: June 23, 2005)		5000
Actual Study Completion Date October 2015
Actual Primary Completion Date October 2015   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

Must meet one of the following criteria:

  • Overweight
  • Previous knee injury or surgery
  • Knee pain during the past year. Participants do not need to have current knee pain to take part in the study.
  • Parent or sibling who had knee replacement

Exclusion Criteria:

  • Rheumatoid arthritis
  • Joint replacements in both knees
  • Unable to walk without assistance
  • Unable to undergo MRI of the knee
Sex/Gender
Sexes Eligible for Study:All
Ages 45 Years to 79 Years   (Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00080171
Other Study ID Numbers NIAMS-109
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Study Sponsor National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborators
  • GlaxoSmithKline
  • Merck Sharp & Dohme Corp.
  • Novartis
  • Pfizer
Investigators
Study Director:Gayle Lester, PhDNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
PRS Account National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Verification Date March 2009